The effects and interactions of GABAergic and dopaminergic agents in the prevention of form deprivation myopia by brief periods of normal vision

Experimental Eye Research

Volumn 110, Issue , 2013, Pages 88-95

  Schmid, Katrina L ^a   Strasberg, Gal ^a   Rayner, Cassie L ^a   Hartfield, Perry J ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

ACh; Chick; DA; Dopamine; FDM; Form deprivation myopia; GABA; NV

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; FORM DEPRIVATION MYOPIA; GABAERGIC SYSTEM; MYOPIA; NONHUMAN; PRIORITY JOURNAL; VISION;

ANIMALS; ANIMALS, NEWBORN; AXIAL LENGTH, EYE; CHICKENS; DOPAMINE AGENTS; DRUG COMBINATIONS; DRUG INTERACTIONS; FORM PERCEPTION; GABA AGENTS; GABA AGONISTS; GABA ANTAGONISTS; INTRAVITREAL INJECTIONS; MALE; MYOPIA; RECEPTORS, DOPAMINE D2; RECEPTORS, GABA; RECEPTORS, GABA-A; RECEPTORS, GABA-B; RETINOSCOPY; SENSORY DEPRIVATION; VISION, OCULAR;

EID: 84875852126     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2013.02.017     Document Type: Article

References (45)

1. Ashby R., Ohlendorf A., Schaeffel F. The effect of ambient illuminance on the development of deprivation myopia in chicks. Invest. Ophthalmol. Vis. Sci. 2009, 50:5348-5354.
2. Bormann J. The 'ABC' of GABA receptors. Trends Pharmacol. Sci. 2000, 21:16-19.
3. Chebib M., Hinton T., Schmid K.L., Brinkworth D., Qian H., Matos S., Kim H.-L., Abdel-Halim H. Novel, potent, and selective GABAC antagonists inhibit myopia development and facilitate learning and memory. J. Pharmacol. Exp. Ther. 2009, 328:448-457.
4. Chebib M., Johnston G.A. GABA-activated ligand gated ion channels: medicinal chemistry and molecular biology. J. Med. Chem. 2000, 43:1427-1447.
5. Contini M., Raviola E. GABAergic synapses made by a retinal dopaminergic neuron. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:1358-1363.
6. Cottriall C.L., McBrien N.A. The M1 muscarinic antagonist pirenzepine reduces myopia and eye enlargement in the tree shrew. Invest. Ophthalmol. Vis. Sci. 1996, 37:1368-1379.
7. Daw N.W., Brunken W.J., Parkinson D. The function of synaptic transmitters in the retina. Annu. Rev. Neurosci. 1989, 12:205-225.
8. C-like receptors on catfish cone- but not rod-driven horizontal cells. J. Neurosci. 1994, 14:2648-2658.
9. Feigenspan A., Bormann J. Facilitation of GABAergic signaling in the retina by receptors stimulating adenylate cyclase. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:10893-10897.
10. Feigenspan A., Wassle H., Bormann J. Pharmacology of GABA receptor Cl-channels in rat retinal bipolar cells. Nature 1993, 361:159-162.
11. Hirasawa H., Puopolo M., Raviola E. Extrasynaptic release of GABA by retinal dopaminergic neurons. J. Neurophysiol. 2009, 102:146-158.
12. Iuvone P.M., Tigges M., Fernandes A., Tigges J. Dopamine synthesis and metabolism in rhesus monkey retina: development, aging, and the effects of monocular visual deprivation. Vis. Neurosci. 1989, 2:465-471.
13. Johnston G.A., Chebib M., Hanrahan J.R., Mewett K.N. Neurochemicals for the investigation of GABA(C) receptors. Neurochem. Res. 2010, 35:1970-1977.
14. Kirsch M., Wagner H.J. Release pattern of endogenous dopamine in teleost retinae during light adaptation and pharmacological stimulation. Vision Res. 1989, 29:147-154.
15. Lam D.M. Neurotransmitters in the vertebrate retina. Invest. Ophthalmol. Vis. Sci. 1997, 38:553-556.
16. A0r) receptors affect ocular growth and form-deprivation myopia. Cutan. Ocul. Toxicol. 2005, 24:187-196.
17. Li X.X., Schaeffel F., Kohler K., Zrenner E. Dose-dependent effects of 6-hydroxy dopamine on deprivation myopia, electroretinograms, and dopaminergic amacrine cells in chickens. Vis. Neurosci. 1992, 9:483-492.
18. Martin G., Williams M., Pettibone D., Yarbrough G., Clineschmidt B., Jones J. Pharmacologic profile of a novel potent direct-acting dopamine agonist, ({thorn})-4-propyl-9 hydroxynaphthoxazine [({thorn})-PHNO]. J. Pharmacol. Exp. Ther. 1984, 230(3):569-576.
19. McBrien N.A., Moghaddam H.O., Reeder A.P. Atropine reduces experimental myopia and eye enlargement via a nonaccommodative mechanism. Invest. Ophthalmol. Vis. Sci. 1993, 34:205-215.
20. McCarthy C.S., Megaw P., Devadas M., Morgan I.G. Dopaminergic agents affect the ability of brief periods of normal vision to prevent form-deprivation myopia. Exp. Eye Res. 2007, 84:100-107.
21. Megaw P.L., Boelen M.G., Morgan I.G., Boelen M.K. Diurnal patterns of dopamine release in chicken retina. Neurochem. Int. 2006, 48:17-23.
22. Morgan W.W., Kamp C.W. A GABAergic influence on the light-induced increase in dopamine turnover in the dark-adapted rat retina in vivo. J. Neurochem. 1980, 34:1082-1086.
23. Morgan I.G., Boelen M.K., Miethke P. Pineal activity is under the control of retinal D1-dopaminergic pathways. Neuroreport 1995, 6(3):446-448.
24. Napper G.A., Brennan N.A., Barrington M., Squires M.A., Vessey G.A., Vingrys A.J. The duration of normal visual exposure necessary to prevent form deprivation myopia in chicks. Vis. Res. 1995, 35:1337-1344.
25. Napper G.A., Brennan N.A., Barrington M., Squires M.A., Vessey G.A., Vingrys A.J. The effect of an interrupted daily period of normal visual stimulation on form deprivation myopia in chicks. Vis. Res. 1997, 37:1557-1564.
26. Nickla D.L., Wildsoet C.F. The effect of the nonspecific nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester on the choroidal compensatory response to myopic defocus in chickens. Optom. Vis. Sci. 2004, 81:111-118.
27. Nickla D.L., Wilken E., Lytle G., Yom S., Mertz J. Inhibiting the transient choroidal thickening response using the nitric oxide synthase inhibitor l-NAME prevents the ameliorative effects of visual experience on ocular growth in two different visual paradigms. Exp. Eye Res. 2006, 83:456-464.
28. Nguyen-Legros J., Versaux-Botteri C., Savy C. Dopaminergic and GABAergic retinal cell populations in mammals. Microsc. Res. Tech. 1997, 36:26-42.
29. Olsen R.W., Sieghart W. International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid (A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update. Pharmacol. Rev. 2008, 60:243-260.
30. Pendrak K., Nguyen T., Lin T., Capehart C., Zhu X., Stone R.A. Retinal dopamine in the recovery from experimental myopia. Curr. Eye Res. 1997, 16:152-157.
31. C receptors in adult porcine cones: evidence from a photoreceptor-glia co-culture model. J. Physiol. 1998, 513(Pt 1):33-42.
32. Qian H. GABAC Receptors in the Vertebrate Retina 1995, University of Utah Health Sciences Center, Salt Lake City (UT). E.F. Helga Kolb, R. Nelson (Eds.).
33. Raviola E., Wiesel T.N. The mechanism of lid-suture myopia. Acta Ophthalmol. Suppl. 1988, 185:91-92.
34. Rohrer B., Iuvone P.M., Stell W.K. Stimulation of dopaminergic amacrine cells by stroboscopic illumination or fibroblast growth factor (bFGF, FGF-2) injections: possible roles in prevention of form-deprivation myopia in the chick. Brain Res. 1995, 686(2):169-181.
35. Schmid K.L., Brinkworth D., Wallace K.M., Payer R., Fritsch C., Lambrou G.N. The effects of GABA-B and GABA-C antagonists on myopia development in chick. Proceedings of the 10th International Conference on Myopia 2004, 20. University of Cambridge, Cambridge, United Kingdom.
36. Schmid K.L., Wildsoet C.F. Inhibitory effects of apomorphine and atropine and their combination on myopia in chicks. Optom. Vis. Sci. 2004, 81:137-147.
37. Seltner R.L., Stell W.K. The effect of vasoactive intestinal peptide on development of form deprivation myopia in the chick: a pharmacological and immunocytochemical study. Vis. Res. 1995, 35:1265-1270.
38. Stone R.A., Lin T., Iuvone P.M., Laties A.M. Postnatal control of ocular growth: dopaminergic mechanisms. Ciba Found. Symp. 1990, 155:45-57. discussion 57-62.
39. Stone R.A., Lin T., Laties A.M., Iuvone P.M. Retinal dopamine and form-deprivation myopia. Proc. Natl. Acad. Sci. U. S. A. 1989, 86:704-706.
40. Stone R.A., Liu J., Sugimoto R., Capehart C., Zhu X., Pendrak K. GABA, experimental myopia, and ocular growth in chick. Invest. Ophthalmol. Vis. Sci. 2003, 44:3933-3946.
41. Vessey K.A., Rushforth D.A., Stell W.K. Glucagon- and secretin-related peptides differentially alter ocular growth and the development of form-deprivation myopia in chicks. Invest. Ophthalmol. Vis. Sci. 2005, 46:3932-3942.
42. Wallman J., Turkel J., Trachtman J. Extreme myopia produced by modest change in early visual experience. Science 1978, 201:1249-1251.
43. Wallman J., Winawer J. Homeostasis of eye growth and the question of myopia. Neuron 2004, 43:447-468.
44. Wu S.M., Maple B.R. Amino acid neurotransmitters in the retina: a functional overview. Vis. Res. 1998, 38:1371-1384.
45. C receptors in the amphibian retina. J. Neurophysiol. 1995, 74:1583-1592.